<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link rel="self" href="http://podcast.peerviewpress.com/aids/AIDSHIVChannel.xml" type="application/rss+xml" />
		<lastBuildDate>Wed, 03 Jun 2009 15:29:42 -0400</lastBuildDate>
		<title>PeerView AIDS/HIV CME/CNE/CPE Audio Podcast</title>
		<itunes:author>PeerView Press</itunes:author>
		<link>http://www.peerviewpress.com</link>
		<generator>Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker</generator>
		<description><![CDATA[PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.]]></description>
		<itunes:subtitle>Thought leader perspectives on current clinical advances in medicine</itunes:subtitle>
		<itunes:summary>PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</itunes:summary>
		<language />
		<copyright>2006</copyright>
		<itunes:owner>
			<itunes:name>PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018</itunes:name>
			<itunes:email>webmaster@peerviewpress.com</itunes:email>
		</itunes:owner>
		<image>
			<url>http://podcast.peerviewpress.com/aids/podcast_AIDSHIVCME-CNE-CPE_144.jpg</url>
			<title>PeerView AIDS/HIV CME/CNE/CPE Audio Podcast</title>
			<link>http://www.peerviewpress.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<itunes:image href="http://podcast.peerviewpress.com/aids/podcast_AIDSHIVCME-CNE-CPE.jpg" />
		<category>Science &amp; Medicine</category>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		<itunes:explicit>no</itunes:explicit>
		<item>
			<title>Jean-Michel Molina, MD, PhD - An Individualized Approach to Selecting Initial Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV discuss the clinical implications of recent developments for initial therapy of HIV. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV discuss the clinical implications of recent developments for initial therapy of HIV. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PPVNE05388r448.mp3" length="25052950" />
			<link>http://podcast.peerviewpress.com/aids/PPVNE05388r448.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PPVNE05388r448.mp3</guid>
			<pubDate>Fri, 29 May 2009 15:21:26 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:03</itunes:duration>
			<itunes:keywords>HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, treatment-naïve</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - An Individualized Approach to Selecting Initial Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PPVNE05388CMEinfo.pdf" length="728287" />
			<link>http://podcast.peerviewpress.com/aids/PPVNE05388CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PPVNE05388CMEinfo.pdf</guid>
			<pubDate>Fri, 29 May 2009 15:21:24 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, treatment-naïve</itunes:keywords>
		</item>
		<item>
			<title>John G. Bartlett, MD - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA05393FCr439.mp3" length="25458312" />
			<link>http://podcast.peerviewpress.com/aids/PA05393FCr439.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05393FCr439.mp3</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:41 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:28</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA05393FCCMEinfo.pdf" length="705917" />
			<link>http://podcast.peerviewpress.com/aids/PA05393FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05393FCCMEinfo.pdf</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:39 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>William A. O’Brien, MD - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04256FCr431.mp3" length="29497568" />
			<link>http://podcast.peerviewpress.com/aids/PA04256FCr431.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04256FCr431.mp3</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:21 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:30:41</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04256FCCMEinfo.pdf" length="727769" />
			<link>http://podcast.peerviewpress.com/aids/PA04256FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04256FCCMEinfo.pdf</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:18 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>Rafael E. Campo, MD - Using NNRTIs Effectively in Clinical Practice: A Case-Based Approach</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this case-based activity, an expert in HIV management discusses first-line treatment considerations in a young African American woman with 3 children, and therapeutic options for a treatment-experienced Hispanic man with HIV.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this case-based activity, an expert in HIV management discusses first-line treatment considerations in a young African American woman with 3 children, and therapeutic options for a treatment-experienced Hispanic man with HIV.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04429FCp152.mp3" length="39661437" />
			<link>http://podcast.peerviewpress.com/aids/PA04429FCp152.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04429FCp152.mp3</guid>
			<pubDate>Wed, 25 Feb 2009 16:29:02 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:41:16</itunes:duration>
			<itunes:keywords>HIV, NNRTI, anitretrviral therapy, adherence, pill burden, viral load, CD4+ cell count, efavirenz,  nevirapine</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Using NNRTIs Effectively in Clinical Practice: A Case-Based Approach</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04429FCCMEinfo.pdf" length="721885" />
			<link>http://podcast.peerviewpress.com/aids/PA04429FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04429FCCMEinfo.pdf</guid>
			<pubDate>Wed, 25 Feb 2009 16:28:53 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, NNRTI, anitretrviral therapy, adherence, pill burden, viral load, CD4+ cell count, efavirenz,  nevirapine</itunes:keywords>
		</item>
		<item>
			<title>Paul E. Sax, MD - Simplified HIV Therapy for All: An Algorithm</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in HIV management discuss the latest data and guidelines for effectively simplifying HIV therapy.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in HIV management discuss the latest data and guidelines for effectively simplifying HIV therapy.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA05061FCr427.mp3" length="26407478" />
			<link>http://podcast.peerviewpress.com/aids/PA05061FCr427.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05061FCr427.mp3</guid>
			<pubDate>Mon, 19 Jan 2009 15:03:12 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:27:28</itunes:duration>
			<itunes:keywords>HIV, simplified regimens, antiretroviral therapy, virologic failure, ICAAC/IDSA, tenofovir, emtricitabine, efavirenz, raltegravir, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE - Simplified HIV Therapy for All: An Algorithm</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA05061FCCMEinfo.pdf" length="751560" />
			<link>http://podcast.peerviewpress.com/aids/PA05061FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05061FCCMEinfo.pdf</guid>
			<pubDate>Mon, 19 Jan 2009 15:02:40 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, simplified regimens, antiretroviral therapy, virologic failure, ICAAC/IDSA, tenofovir, emtricitabine, efavirenz, raltegravir, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>Daniel R. Kuritzkes, MD - Clinical Context for Entry Inhibitors: An Update From Washington</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[The first presentation reviews the latest data on entry inhibitors that target CCR5-tropic HIV, specifically from the recent ICAAC/IDSA conference. This discussion focuses on how these data can be applied to clinical practice, or not. The second presentation explores ongoing safety issues and concerns associated with entry inhibitors, focusing on long-term updates from clinical trials. The third and final presentation centers on the overall clinical approach to the treatment-experienced patient and entry inhibitors, including the use and interpretation of assays, drug interactions, appropriate patient selection.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>The first presentation reviews the latest data on entry inhibitors that target CCR5-tropic HIV, specifically from the recent ICAAC/IDSA conference. This discussion focuses on how these data can be applied to clinical practice, or not. The second presentation explores ongoing safety issues and concerns associated with entry inhibitors, focusing on long-term updates from clinical trials. The third and final presentation centers on the overall clinical approach to the treatment-experienced patient and entry inhibitors, including the use and interpretation of assays, drug interactions, appropriate patient selection.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04879FCr437.mp3" length="31356932" />
			<link>http://podcast.peerviewpress.com/aids/PA04879FCr437.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04879FCr437.mp3</guid>
			<pubDate>Wed, 24 Dec 2008 14:10:16 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:32:34</itunes:duration>
			<itunes:keywords>entry inhibitors, HIV, CD4, tropism, X4, R5, CXCR-4, ICAAC, IDSA, MERIT, MOTIVATE</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Clinical Context for Entry Inhibitors: An Update From Washington</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04879FCCMEinfo.pdf" length="645999" />
			<link>http://podcast.peerviewpress.com/aids/PA04879FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04879FCCMEinfo.pdf</guid>
			<pubDate>Wed, 24 Dec 2008 14:10:12 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>entry inhibitors, HIV, CD4, tropism, X4, R5, CXCR-4, ICAAC, IDSA, MERIT, MOTIVATE</itunes:keywords>
		</item>
		<item>
			<title>Anton Pozniak, MD, FRCP - Simplified Therapy for HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in HIV management discuss the latest data on simplified or fixed dose regimens, as well as strategies for simplifying initial and subsequent therapy.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in HIV management discuss the latest data on simplified or fixed dose regimens, as well as strategies for simplifying initial and subsequent therapy.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA05060FCr417.mp3" length="28371997" />
			<link>http://podcast.peerviewpress.com/aids/PA05060FCr417.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05060FCr417.mp3</guid>
			<pubDate>Wed, 03 Dec 2008 15:19:55 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:29:27</itunes:duration>
			<itunes:keywords>HIV, simplifying antiretroviral therapy, virologic suppression, fixed dose regimen, immunologic outcomes, adherence, protease inhibitors, NNRTIs</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Simplified Therapy for HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA05060FCCMECEinfo.pdf" length="744577" />
			<link>http://podcast.peerviewpress.com/aids/PA05060FCCMECEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA05060FCCMECEinfo.pdf</guid>
			<pubDate>Wed, 03 Dec 2008 15:14:55 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, simplifying antiretroviral therapy, virologic suppression, fixed dose regimen, immunologic outcomes, adherence, protease inhibitors, NNRTIs</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Highlights from AIDS 2008: A Roundtable Discussion</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[The purpose of this panel-based educational activity is to provide a balanced, peer-to-peer perspective on some of the key issues facing HIV specialists, based on data presented at the XVII International AIDS Conference, August 3-8, 2008. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>The purpose of this panel-based educational activity is to provide a balanced, peer-to-peer perspective on some of the key issues facing HIV specialists, based on data presented at the XVII International AIDS Conference, August 3-8, 2008. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04185FCe023.mp3" length="43600758" />
			<link>http://podcast.peerviewpress.com/aids/PA04185FCe023.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04185FCe023.mp3</guid>
			<pubDate>Tue, 11 Nov 2008 13:00:08 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:45:19</itunes:duration>
			<itunes:keywords>17th International AIDS Conference, AIDS 2008, HIV, NNRTI, viral load, protease inhibitor, abacavir, tenofovir</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Highlights from AIDS 2008: A Roundtable Discussion</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04185FCCMEinfo.pdf" length="343205" />
			<link>http://podcast.peerviewpress.com/aids/PA04185FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04185FCCMEinfo.pdf</guid>
			<pubDate>Thu, 06 Nov 2008 13:00:10 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>17th International AIDS Conference, AIDS 2008, HIV, NNRTI, viral load, protease inhibitor, abacavir, tenofovir</itunes:keywords>
		</item>
		<item>
			<title>Kimberly Y. Smith, MD, MPH - NNRTIs in HIV: Interpreting Data for Clinical Application</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an integral part of the success of antiretroviral therapy. Data continue to be published and presented at major medical conferences that provide updated information on the optimal use of current and emerging agents within this class for treatment-naïve as well as treatment-experienced patients. This program explores the clinical implications of these data.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an integral part of the success of antiretroviral therapy. Data continue to be published and presented at major medical conferences that provide updated information on the optimal use of current and emerging agents within this class for treatment-naïve as well as treatment-experienced patients. This program explores the clinical implications of these data.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04428FCr416.mp3" length="24904190" />
			<link>http://podcast.peerviewpress.com/aids/PA04428FCr416.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04428FCr416.mp3</guid>
			<pubDate>Thu, 30 Oct 2008 10:50:20 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:25:50</itunes:duration>
			<itunes:keywords>NNRTI, efavirenz, etravirine, emtricitabine, abacavir, lamivudine, SMART, DUET, raltegravir, rilpivirine, IDX899, RDEA806</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - NNRTIs in HIV: Interpreting Data for Clinical Application</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04428FCCMEinfo.pdf" length="329550" />
			<link>http://podcast.peerviewpress.com/aids/PA04428FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04428FCCMEinfo.pdf</guid>
			<pubDate>Thu, 30 Oct 2008 10:50:16 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>NNRTI, efavirenz, etravirine, emtricitabine, abacavir, lamivudine, SMART, DUET, raltegravir, rilpivirine, IDX899, RDEA806</itunes:keywords>
		</item>
		<item>
			<title>David Wohl, MD - When HAART Fails: The Role of Adherence in Successful HIV Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss the importance of treatment adherence for patients with this condition. Factors associated with nonadherence are explored, and strategies to improve adherence are highlighted.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04263FCr408.mp3" length="20604644" />
			<link>http://podcast.peerviewpress.com/aids/PA04263FCr408.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04263FCr408.mp3</guid>
			<pubDate>Fri, 29 Aug 2008 11:02:47 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:21:22</itunes:duration>
			<itunes:keywords>Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - When HAART Fails: The Role of Adherence in Successful HIV Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04263FCCMEinfo.pdf" length="531831" />
			<link>http://podcast.peerviewpress.com/aids/PA04263FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04263FCCMEinfo.pdf</guid>
			<pubDate>Fri, 29 Aug 2008 11:02:45 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Adherence, antiretrovirals, PI, NNRTI, NRTI, pill burden, regimen complexity, forgiveness, food, alcohol</itunes:keywords>
		</item>
		<item>
			<title>Donald P. Kotler, MD - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file or full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04255FCr403.mp3" length="23759817" />
			<link>http://podcast.peerviewpress.com/aids/PA04255FCr403.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04255FCr403.mp3</guid>
			<pubDate>Thu, 31 Jul 2008 15:15:46 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:24:39</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary />
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04255FCCMEinfo.pdf" length="281021" />
			<link>http://podcast.peerviewpress.com/aids/PA04255FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04255FCCMEinfo.pdf</guid>
			<pubDate>Thu, 31 Jul 2008 15:15:40 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - Advances in the Use of NNRTI-Based Treatment in HIV: Optimizing Patient Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts evaluate recent data on the efficacy and safety of NNRTI-based regimens for treatment-naïve patients with HIV. An analysis of how patient-related and medication-related factors play a role in selecting initial NNRTI-based regimens is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04427FCr401.mp3" length="19445225" />
			<link>http://podcast.peerviewpress.com/aids/PA04427FCr401.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04427FCr401.mp3</guid>
			<pubDate>Tue, 17 Jun 2008 11:13:47 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:09</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Advances in the Use of NNRTI-Based Treatment in HIV: Optimizing Patient Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04427FCCMEinfo.pdf" length="288047" />
			<link>http://podcast.peerviewpress.com/aids/PA04427FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04427FCCMEinfo.pdf</guid>
			<pubDate>Tue, 17 Jun 2008 11:11:49 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTIs, DHHS, efavirenz, nevirapine, treatment-naïve, HAART</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Maintaining Optimal Virologic Suppression in HIV: When and How to Switch Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss recent issues on when to initiate antiretroviral agents and how and when to switch therapy.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04259FCe019.mp3" length="37626449" />
			<link>http://podcast.peerviewpress.com/aids/PA04259FCe019.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04259FCe019.mp3</guid>
			<pubDate>Fri, 30 May 2008 09:58:35 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:39:06</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Maintaining Optimal Virologic Suppression in HIV: When and How to Switch Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04259FCCMEinfo.pdf" length="298247" />
			<link>http://podcast.peerviewpress.com/aids/PA04259FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04259FCCMEinfo.pdf</guid>
			<pubDate>Fri, 30 May 2008 09:58:32 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment failure, virologic failure, immunologic failure, clinical progression, PI, NNRTI</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Advances in HIV Management: An Update From Boston</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present recent data on the efficacy and safety of a number of antiretroviral regimens used in the management of treatment-naïve patients. A discussion on the clinical implications of updated DHHS guidelines for the initiation of treatment is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04181FCs474.mp3" length="28576797" />
			<link>http://podcast.peerviewpress.com/aids/PA04181FCs474.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04181FCs474.mp3</guid>
			<pubDate>Wed, 30 Apr 2008 14:41:48 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:29:40</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Advances in HIV Management: An Update From Boston</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04181FCCMEinfo.pdf" length="273994" />
			<link>http://podcast.peerviewpress.com/aids/PA04181FCFCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04181FCCMEinfo.pdf</guid>
			<pubDate>Wed, 30 Apr 2008 14:40:48 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, CROI, lipoatrophy, SMART, CASTLE, M05-730, ACTG 5142</itunes:keywords>
		</item>
		<item>
			<title>Daniel R. Kuritzkes, MD - Integrating New and Emerging Agents in HIV: An Update From Boston</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging agents for the management of treatment-experienced patients with HIV.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging agents for the management of treatment-experienced patients with HIV.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04547FCr381.mp3" length="27238910" />
			<link>http://podcast.peerviewpress.com/aids/PA04547FCr381.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04547FCr381.mp3</guid>
			<pubDate>Thu, 17 Apr 2008 16:41:50 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:28:16</itunes:duration>
			<itunes:keywords>AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Integrating New and Emerging Agents in HIV: An Update From Boston</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04547FCCMEinfo.pdf" length="208426" />
			<link>http://podcast.peerviewpress.com/aids/PA04547FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04547FCCMEinfo.pdf</guid>
			<pubDate>Thu, 17 Apr 2008 16:41:45 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, CROI, raltegravir, maraviroc, etravirine, CCR5, DUET, BENCHMRK, MOTIVATE, tropism assay, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Individualized Therapy for Treatment-Naïve Patients With HIV: What To Use and When To Initiate</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV review important issues to consider when individualizing antiretroviral therapy. The treatment of patients with HIV and comorbid HBV, HCV, or renal insufficiency, as well as management strategies for pregnant women are featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04154FCe011.mp3" length="33184379" />
			<link>http://podcast.peerviewpress.com/aids/PA04154FCe011.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04154FCe011.mp3</guid>
			<pubDate>Tue, 08 Apr 2008 11:11:25 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:34:28</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Individualized Therapy for Treatment-Naïve Patients With HIV: What To Use and When To Initiate</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04154FCCMEinfo.pdf" length="282784" />
			<link>http://podcast.peerviewpress.com/aids/PA04451FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04154FCCMEinfo.pdf</guid>
			<pubDate>Tue, 08 Apr 2008 11:10:22 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, atazanavir, lopinavir, efavirenz, nevirapine, pregnancy, hepatitis, coinfection, zidovudine, lamivudine</itunes:keywords>
		</item>
		<item>
			<title>Kathleen Squires, MD - Considerations for Managing HIV in Women</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present important issues regarding the management of HIV in women. The treatment of HIV in pregnant women is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04268FCr389.mp3" length="22151928" />
			<link>http://podcast.peerviewpress.com/aids/PA04268FCr389.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04268FCr389.mp3</guid>
			<pubDate>Fri, 28 Mar 2008 15:47:42 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:22:58</itunes:duration>
			<itunes:keywords>HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Considerations for Managing HIV in Women</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04268FCCMEinfo.pdf" length="224257" />
			<link>http://podcast.peerviewpress.com/aids/PA04268FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04268FCCMEinfo.pdf</guid>
			<pubDate>Fri, 28 Mar 2008 15:47:41 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, pregnancy, contraception, DHHS, efavirenz, nelfinavir, antitretrovirals, mother-to-child transmission, zidovudine</itunes:keywords>
		</item>
		<item>
			<title>Eric Daar, MD - Updated DHHS Guidelines for HIV: Incorporating Recent Updates Into Clinical Practice</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV assess the most recent updates to the DHHS guidelines on HIV management and discuss how these recommendations should be implemented into clinical practice. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03620FC3r360.mp3" length="15297021" />
			<link>http://podcast.peerviewpress.com/aids/PA03620FC3r360.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03620FC3r360.mp3</guid>
			<pubDate>Wed, 27 Feb 2008 12:37:20 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:15:50</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Updated DHHS Guidelines for HIV: Incorporating Recent Updates Into Clinical Practice</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03620FC3CMEinfo.pdf" length="273232" />
			<link>http://podcast.peerviewpress.com/aids/PA03620FC3CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03620FC3CMEinfo.pdf</guid>
			<pubDate>Wed, 27 Feb 2008 12:37:20 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, DHHS, guidelines,CD4 counts, abacavir, atazanavir, lopinavir, efavirenz, tipranavir, darunavir, etravirine, nelfinavir, fosamprenavir, resistance testing, genotype, haplotype, hepatitis B coinfection, pregnancy</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - Optimizing Initial Antiretroviral Therapy: PI- Versus NNRTI-based Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of HIV will examine key issues to consider when choosing an initial antiretroviral strategy. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03539FC2p130.mp3" length="50273455" />
			<link>http://podcast.peerviewpress.com/aids/PA03539FC2p130.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03539FC2p130.mp3</guid>
			<pubDate>Tue, 15 Jan 2008 16:20:37 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:52:16</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimizing Initial Antiretroviral Therapy: PI- Versus NNRTI-based Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03539FC2CMEinfo.pdf" length="284175" />
			<link>http://podcast.peerviewpress.com/aids/PA03539FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03539FC2CMEinfo.pdf</guid>
			<pubDate>Tue, 15 Jan 2008 16:20:35 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, NNRTI, PI, zidovudine, lamivudine, tenofovir, emtricitabine, abacavir, efavirenz, nevirapine, atazanavir, lopinavir, fosamprenavir, darunavir, ritonavir, treatment-naïve, 2NN, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>Ian Frank, MD - Update from IAS, ICAAC &amp; IDSA: Focus on New and Emerging HIV Therapies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on efficacy and safety of new and emerging antiretroviral agents. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA04089FCs437.mp3" length="33286361" />
			<link>http://podcast.peerviewpress.com/aids/PA04089FCs437.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04089FCs437.mp3</guid>
			<pubDate>Wed, 09 Jan 2008 13:36:10 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:34:34</itunes:duration>
			<itunes:keywords>AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Update from IAS, ICAAC &amp; IDSA: Focus on New and Emerging HIV Therapies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA04089FCCMEinfo.pdf" length="218122" />
			<link>http://podcast.peerviewpress.com/aids/PA04089FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA04089FCCMEinfo.pdf</guid>
			<pubDate>Wed, 09 Jan 2008 13:36:08 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, maraviroc, vicriviroc, raltegravir, elvitegravir, etravirine, TMC125, rilpivirine, TMC278, treatment experienced, CCR5, integrase inhibitors, ICAAC, IDSA, IAS, CXCR4, dual/mixed tropic, darunavir</itunes:keywords>
		</item>
		<item>
			<title>Kathleen Squires, MD - Challenges in HIV Therapy: Initial Options and Switching Strategies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies.
]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present current data on initial treatment options in HIV as well as efficacy and safety data on switching strategies.
</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03538FC3s429.mp3" length="24827431" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC3s429.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC3s429.mp3</guid>
			<pubDate>Fri, 07 Dec 2007 13:44:38 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:36</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Challenges in HIV Therapy: Initial Options and Switching Strategies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03538FC3CMEinfo.pdf" length="241953" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC3CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC3CMEinfo.pdf</guid>
			<pubDate>Fri, 07 Dec 2007 13:44:36 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, darunavir, maraviroc, raltegravir, stavudine, abacavir, integrase inhibitor, CD4, DHHS, IAS-USA, cholesterol</itunes:keywords>
		</item>
		<item>
			<title>Ian Frank, MD - Optimal Use of Initial Treatments and Switching Strategies in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of HIV reviews initial treatment strategies in HIV and explores issues related to switching antiretroviral therapies.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03539FC1p122.mp3" length="66547594" />
			<link>http://podcast.peerviewpress.com/aids/PA03539FC1p122.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03539FC1p122.mp3</guid>
			<pubDate>Thu, 29 Nov 2007 14:46:11 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:55:22</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimal Use of Initial Treatments and Switching Strategies in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03539FC1CMEinfo.pdf" length="100609" />
			<link>http://podcast.peerviewpress.com/aids/PA03539FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03539FC1CMEinfo.pdf</guid>
			<pubDate>Thu, 29 Nov 2007 14:46:09 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, treatment-naïve, treatment experienced, zidovudine, lamivudine, abacavir, tenofovir, emtricitabine, atazanavir, fosamprenavir, lopinavir, darunavir, efavirenz, nevirapine, etravirine</itunes:keywords>
		</item>
		<item>
			<title>Donald P. Kotler, MD - Recent Perspectives on Metabolic Issues and Lipodystrophy in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on the risk of patients with HIV developing metabolic abnormalities while on antiretroviral therapy. Treatment options to manage these abnormalities are featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03530FCs419.mp3" length="16485509" />
			<link>http://podcast.peerviewpress.com/aids/PA03530FCs419.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03530FCs419.mp3</guid>
			<pubDate>Tue, 09 Oct 2007 15:50:23 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:17:04</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Recent Perspectives on Metabolic Issues and Lipodystrophy in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03530FCCMEinfo.pdf" length="238059" />
			<link>http://podcast.peerviewpress.com/aids/PA03530FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03530FCCMEinfo.pdf</guid>
			<pubDate>Tue, 09 Oct 2007 15:50:16 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>William A. O’Brien, MD - Using Fixed-Dose Antiretroviral Therapy in HIV: An Update From Sydney</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents.	]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on fixed-dose antiretroviral agents.	</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03525FC2s422.mp3" length="40235768" />
			<link>http://podcast.peerviewpress.com/aids/PA03525FC2s422.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03525FC2s422.mp3</guid>
			<pubDate>Wed, 03 Oct 2007 10:49:52 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:41:49</itunes:duration>
			<itunes:keywords>AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Using Fixed-Dose Antiretroviral Therapy in HIV: An Update From Sydney</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03525FC2CMEinfo.pdf" length="266400" />
			<link>http://podcast.peerviewpress.com/aids/PA03525FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03525FC2CMEinfo.pdf</guid>
			<pubDate>Wed, 03 Oct 2007 10:48:58 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, efavirenz, atazanavir, lopinavir, fosamprenavir, tenofovir, emtricitabine, zidovudine, lamivudine, study 934, study 903, KLEAN, LAKE, SHARE, ALERT, fixed-dose, antiretrovirals</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc - Optimizing New and Emerging Antiretroviral Agents in Fully Active Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present the most current data on the efficacy and safety of newer and emerging antiretroviral agents used in the management of this condition.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03928FCr344.mp3" length="38366237" />
			<link>http://podcast.peerviewpress.com/aids/PA03928Fr344.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03928FCr344.mp3</guid>
			<pubDate>Tue, 18 Sep 2007 17:47:17 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:39:52</itunes:duration>
			<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, AIDS, HIV</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimizing New and Emerging Antiretroviral Agents in Fully Active Regimens for Treatment-Experienced Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03928FCCMEinfo.pdf" length="259017" />
			<link>http://podcast.peerviewpress.com/aids/PA03928FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03928FCCMEinfo.pdf</guid>
			<pubDate>Tue, 18 Sep 2007 17:47:14 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS 2007, International AIDS Conference, 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, etravirine, darunavir, tipranavir, raltegravir, maraviroc, vicriviroc, elvitegravir, HIV, AIDS</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien, MD - Optimizing Viral Suppression: Strategies for Initial Antiretroviral Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV discuss the pros and cons of initiating antiretroviral therapy earlier than what is currently recommended. Issues of safety, resistance, and tolerability that need to be considered when selecting an initial treatment strategy are featured. The impact of antiretrovirals on lipid parameters and cardiovascular risk is discussed. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss the pros and cons of initiating antiretroviral therapy earlier than what is currently recommended. Issues of safety, resistance, and tolerability that need to be considered when selecting an initial treatment strategy are featured. The impact of antiretrovirals on lipid parameters and cardiovascular risk is discussed. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03538FC2r331.mp3" length="21397971" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC2r331.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC2r331.mp3</guid>
			<pubDate>Thu, 09 Aug 2007 09:15:29 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:22:11</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, CD4, DHHS, IAS-USA, cardiovascular, MI, dyslipidemia, diabetes, hypertension, ATHENA</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimizing Viral Suppression: Strategies for Initial Antiretroviral Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03538FC2CMEinfo.pdf" length="102646" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC2CMEinfo.pdf</guid>
			<pubDate>Thu, 09 Aug 2007 09:15:11 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, antiretroviral, efavirenz, tenofovir, emtricitabine, zidovudine, lamivudine, atazanavir, fosamprenavir, lopinavir, ritonavir, CD4, DHHS, IAS-USA, cardiovascular, MI, dyslipidemia, diabetes, hypertension, ATHENA</itunes:keywords>
		</item>
		<item>
			<title>W. David Hardy, MD - HIV in Young Adults: An Often Overlooked Epidemic</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV discuss the incidence of HIV in adolescents and young adults. Management considerations for the treatment of HIV in young adults are featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03540FCr319.mp3" length="16686317" />
			<link>http://podcast.peerviewpress.com/aids/PA03540FCr319.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03540FCr319.mp3</guid>
			<pubDate>Thu, 26 Jul 2007 11:51:56 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:17:17</itunes:duration>
			<itunes:keywords>AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - HIV in Young Adults: An Often Overlooked Epidemic</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03540FCCMEInfo.pdf" length="119655" />
			<link>http://podcast.peerviewpress.com/aids/PA03540FCCMEInfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03540FCCMEInfo.pdf</guid>
			<pubDate>Thu, 26 Jul 2007 11:51:34 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, adolescents, young adults, efavirenz, tenofovir, emtricitabine, atazanavir, lopinavir, fosamprenavir, ritonavir, zidovudine, lamivudine, didanosine, contraception, pregnancy, pill burden, adherence, simplification, nevirapine, abacavir</itunes:keywords>
		</item>
		<item>
			<title>Sally L. Hodder, MD - Updated Data from Los Angeles: The Impact of HIV and HIV Therapies on Metabolic Outcomes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV present recent data on the effects of antiretrovirals on metabolic and body-composition parameters. Cohort data on HIV and cardiovascular risk and emerging management strategies for dyslipidemia in HIV are featured. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03538FC1s389.mp3" length="19181911" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC1s389.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC1s389.mp3</guid>
			<pubDate>Thu, 17 May 2007 09:17:02 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:19:53</itunes:duration>
			<itunes:keywords>AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Updated Data from Los Angeles: The Impact of HIV and HIV Therapies on Metabolic Outcomes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03538FC1CMEinfo.pdf" length="107265" />
			<link>http://podcast.peerviewpress.com/aids/PA03538FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03538FC1CMEinfo.pdf</guid>
			<pubDate>Thu, 17 May 2007 09:16:39 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, metabolic, lipids, cholesterol, triglycerides, HDL, LDL, cardiovascular, body composition, atazanavir, efavirenz, lopinavir, fosamprenavir, tenofovir, stavudine, zidovudine, ezetimibe, leptin, BMS-089, ACTG-5142, SMART, D:A:D, ACTG 5095, KLEAN</itunes:keywords>
		</item>
		<item>
			<title>Calvin Cohen, MD, MSc  - Re-evaluating Treatment Goals and Prognosis in Treatment-Experienced Patients with HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV use case-based scenarios to evaluate management strategies for treatment-experienced patients with HIV. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03695FC2r281.mp3" length="37132881" />
			<link>http://podcast.peerviewpress.com/aids/PA03695FC2r281.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03695FC2r281.mp3</guid>
			<pubDate>Thu, 03 May 2007 15:04:07 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:38:35</itunes:duration>
			<itunes:keywords>AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Re-evaluating Treatment Goals and Prognosis in Treatment-Experienced Patients with HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03695FC2CMEinfo.pdf" length="277051" />
			<link>http://podcast.peerviewpress.com/aids/PA03695FC2CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03695FC2CMEinfo.pdf</guid>
			<pubDate>Thu, 03 May 2007 15:03:54 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>AIDS, HIV, persistent low level viremia, treatment-experienced, treatment goals, viral suppression, efavirenz, atazanavir, fosamprenavir, lopinavir, saquinavir, tenofovir, darunavir, tenofovir, emtricitabine, nevirapine, ritonavir, DHHS, IAS-USA</itunes:keywords>
		</item>
		<item>
			<title>William A. O&apos;Brien - Understanding Implications of Updated Guidelines for Initiating Antiretroviral Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of HIV review the most recent guidelines for the initiation of antiretroviral therapy in HIV. Data used as evidence for some of the updated recommendations will be featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/aids/PA03620FC1r302.mp3" length="19202014" />
			<link>http://podcast.peerviewpress.com/aids/PA03620FC1r302.mp3</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03620FC1r302.mp3</guid>
			<pubDate>Fri, 27 Apr 2007 15:29:59 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:19:54</itunes:duration>
			<itunes:keywords>HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Understanding Implications of Updated Guidelines for Initiating Antiretroviral Therapy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf" length="267183" />
			<link>http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/aids/PA03620FC1CMEinfo.pdf</guid>
			<pubDate>Fri, 27 Apr 2007 15:29:39 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, AIDS, DHHS, IAS-USA, guidelines, efavirenz, atazanavir, lopinavir, saquinavir, darunavir, tipranavir, tenofovir, emtricitabine, lamivudine, 3TC, abacavir, zidovudine, nevirapine, fosamprenavir, treatment naïve, treatment-experienced</itunes:keywords>
		</item>
	</channel>
</rss>